glp-1 bcbs Blue Cross Blue Shield Drops Coverage of Obesity Drugs GLP-1 Drugs Could Raise Employer

You should not use Wegovy if you or an immediate family member has ever had medullary thyroid carcinoma (MTC), or multiple endocrine neoplasia syndrome type 2 (MEN 2)

If you skip the rehab and just inject something, youll get a worse outcome

FDA-approved options for medical weight loss now include injectable medications like Wegovy, Zepbound, Saxenda, and Mounjaro, as well as oral medications like Foundayo, Rybelsus, and Oral Wegovy

Unlike most membrane scaffold protein (MSP) Nanodiscs available on the market, Dima Biotechnologys Synthetic Nanodisc is developed using a eukaryotic expression system, enabling production directly from intact cells

4 Medicare coverage for GLP-1 drugs for obesity will begin in spring 2026, starting with a pilot program that could become mandatory in 2027

A complete history is needed to see how weight impacts your health